6683-46-1 Usage
General Description
1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene, also known as tetramethylnaphthalene, is a chemical compound belonging to the class of hydrocarbons. It is derived from naphthalene and is composed of four methyl groups attached to the naphthalene ring. This chemical is often used as a synthetic substitute for natural musk in the fragrance industry, due to its similar aroma. It is also used as a precursor in the production of other chemicals and as a chemical intermediate in organic synthesis. Tetramethylnaphthalene is a colorless liquid with a high boiling point and low volatility, making it suitable for various industrial applications. However, it is important to handle this chemical with care, as it is flammable and may cause irritation upon contact with skin or eyes.
Check Digit Verification of cas no
The CAS Registry Mumber 6683-46-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,8 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6683-46:
(6*6)+(5*6)+(4*8)+(3*3)+(2*4)+(1*6)=121
121 % 10 = 1
So 6683-46-1 is a valid CAS Registry Number.
InChI:InChI=1/C14H20/c1-13(2)9-10-14(3,4)12-8-6-5-7-11(12)13/h5-8H,9-10H2,1-4H3
6683-46-1Relevant articles and documents
COMPOUNDS AND METHODS FOR INHIBITING CYP26 ENZYMES
-
Page/Page column 17, (2018/07/05)
Compounds described herein are inhibitors of retinoic acid inducible P450 (CYP26) enzymes, and are useful for treating diseases that are responsive to retinoids. Certain compounds have retinoid activity, are resistant to CYP26-mediated catabolism, and are used for treating diseases that are responsive to retinoids.
DIHYDROINDENE AND TETRAHYDRONAPHTHALENE COMPOUNDS
-
Paragraph 0195; 0196, (2018/08/09)
The invention provides compounds of formula I: and salts thereof, as well as pharmaceutical compositions comprising such compounds. The compounds are useful for treating cancers, Alzheimer's disease, and conditions associated with demyelination.
18-20 MEMBER BI-POLYCYCLIC COMPOUNDS
-
Page/Page column 31, (2016/01/16)
The invention relates to 18-20 member bi-polycyclic compounds, methods of making these compounds, and methods of using them in treating hyperproliferative disorders (e.g., cancer) and non-malignant tumors; promoting muscle formation; inhibiting muscle degeneration or the loss of muscle mass or muscle function; and myofibers ex vivo.